FrancophonIA/ELRC3.0 huggingface dataset:
English: Any applications for the licensing of medicines containing comfrey root have to be submitted to the national authorities responsible for medicinal products, which will assess the application for the herbal medicine and take into account the scientific conclusions of the HMPC.
Slovenian: Vlogo za izdajo dovoljenja za promet z zdravili, ki vsebujejo korenino navadnega gabeza, je treba predložiti pristojnemu nacionalnemu organu za zdravila, ki bo to vlogo za izdajo dovoljenja za promet z zdravilom rastlinskega izvora ocenil in upošteval znanstvene zaključke odbora HMPC.
English: Further information on the HMPC assessment of comfrey root medicines, including details of the Committee's conclusions, can be found under the tab ‘All documents' on the Agency's website: ema.europa.eu/Find medicine/Herbal medicines for human use.
Slovenian: Dodatne informacije o oceni zdravil, ki vsebujejo korenino navadnega gabeza, ki jo je opravil odbor HMPC, vključno z njegovimi znanstvenimi zaključki, so na voljo na spletni strani agencije pod zavihkom „Vsi dokumenti“: ema.europa.eu/Find medicine/Herbal medicines for human use.
English: Information on the use and licensing of comfrey root medicines in EU Member States should be obtained from the relevant national authorities.
Slovenian: Za informacije o uporabi in dovoljenjih za promet z zdravili, ki vsebujejo korenino navadnega gabeza, v državah članicah EU se obrnite na pristojni nacionalni organ.
English: Comfrey root contains substances known as pyrrolizidine alkaloids, which have toxic effects on the liver when taken by mouth.
Slovenian: Korenina navadnega gabeza vsebuje snovi, imenovane pirolizidinski alkaloidi, ki imajo toksičen učinek na jetra, če se uživajo peroralno (skozi usta).
English: In its assessment, the HMPC considered the well documented use of comfrey root for the relief of symptoms of minor sprains and bruises.
Slovenian: Pri svoji oceni je odbor HMPC upošteval dobro dokumentirano uporabo korenine navadnega gabeza za lajšanje simptomov manjših zvinov in podplutb.
English: How are comfrey root medicines approved in the EU?
Slovenian: Kako so zdravila, ki vsebujejo korenino navadnega gabeza, odobrena v EU?
English: Detailed instructions on how to take comfrey root medicines and who can use them can be found in the package leaflet that comes with the medicine.
Slovenian: Podrobna navodila o uporabi zdravil s korenino navadnega gabeza in o tem, kdo jih sme uporabljati, so v navodilu za uporabo, ki je priloženo posameznemu zdravilu.
English: The HMPC concluded that, on the basis of its long-standing use, these comfrey root medicines can be used for the relief of symptoms of minor sprains and bruises.
Slovenian: Odbor HMPC je zaključil, da se lahko na podlagi izkušenj dolgoletne uporabe zdravila s korenino navadnega gabeza uporabljajo za lajšanje simptomov manjših zvinov in podplutb.
English: For more information about treatment with comfrey root medicines, read the package leaflet that comes with the medicine or contact your doctor or pharmacist.
Slovenian: Za več informacij o zdravljenju z zdravili, ki vsebujejo korenino navadnega gabeza, preberite navodilo za uporabo, ki je priloženo posameznemu zdravilu, ali se posvetujte z zdravnikom ali farmacevtom.
English: What evidence supports the use of comfrey root medicines?
Slovenian: Kateri dokazi podpirajo uporabo zdravil, ki vsebujejo korenino navadnega gabeza?
English: Other information about comfrey root medicines
Slovenian: Druge informacije o zdravilih, ki vsebujejo korenino navadnega gabeza
English: What are the risks associated with comfrey root medicines?
Slovenian: Kakšna tveganja so povezana z zdravili, ki vsebujejo korenino navadnega gabeza?
English: For practical information about using comfrey root medicines, patients should read the package leaflet that comes with the medicine or contact their doctor or pharmacist.
Slovenian: Za praktične informacije o njihovi uporabi naj bolniki preberejo navodilo za uporabo, ki je priloženo posameznemu zdravilu, ali se posvetujejo z zdravnikom ali farmacevtom.
English: What is comfrey root?
Slovenian: Kaj je korenina navadnega gabeza?
English: No significant risk is expected when comfrey root medicines are used on the skin for short periods.
Slovenian: Kadar se zdravila s korenino navadnega gabeza uporabljajo na koži in je njihova uporaba kratkotrajna, ni pričakovati pomembnih tveganj.
English: Comfrey root
Slovenian: Korenina navadnega gabeza
English: - a recent serious injury.
Slovenian: o nedavna huda poškodba.
English: Date of first authorisation: 28 July 2009 Date of latest renewal: 16 May 2014
Slovenian: Datum pridobitve dovoljenja za promet: 28. julij 2009 Datum zadnjega podaljšanja: 16. maj 2014
English: Do not give this medicine to children because it does not work.
Slovenian: Ne dajajte tega zdravila otrokom ali mladostnikom, ker ne deluje.
English: These may be due to rare decrease of some blood cells
Slovenian: To so lahko znaki redkega zmanjšanja števila določenih krvnih celic.
English: Some other medicines may influence the use of Clopidogrel Teva or vice versa.
Slovenian: Nekatera druga zdravila lahko vplivajo na uporabo zdravila Klopidogrel Teva in obratno.
English: The mean CHADS2 score was 2.0 (range 0-6).
Slovenian: CHADS2 je bila 2,0 (razpon: od 0 do 6).
English: Clopidogrel has been evaluated for safety in more than 44,000 patients who have participated in clinical studies, including over 12,000 patients treated for 1 year or more.
Slovenian: Varnost klopidogrela so ovrednotili pri več kot 44.000 bolnikih, ki so sodelovali v kliničnih študijah, vključno z več kot 12.000 bolniki, ki so se zdravili 1 leto ali več.
English: - a planned surgery (including dental) in the next seven days.
Slovenian: o načrtovan kirurški poseg (vključno na zobeh) v naslednjih 7 dneh.
English: Detailed information on this medicinal product is available on the website of the European Medicines Agency http://www.ema.europa.eu/.
Slovenian: Podrobne informacije o zdravilu so objavljene na spletni strani Evropske agencije za zdravila: http://www.ema.europa.eu/.
English: Put the tablet in your mouth and swallow with water or another liquid.
Slovenian: Tableto položite v usta in jo zaužijte z vodo ali primerno tekočino.
English: The patient population included 41.8% women.
Slovenian: V populaciji bolnikov je bilo 41,8 % žensk.
English: • Adults and elderly Clopidogrel should be given as a single daily dose of 75 mg.
Slovenian: • Odrasli in starostniki Klopidogrel se mora dajati kot enkratni dnevni odmerek 75 mg.
English: The marketing authorisation holder shall submit periodic safety update reports for this product in accordance with the requirements set out in the list of Union reference dates (EURD list) ) provided for under Article 107c(7) of Directive 2001/83/EC and published on the European medicines web-portal
Slovenian: • Redno posodobljena poročila o varnosti zdravila (PSUR) Imetnik dovoljenja za promet z zdravilom mora redno posodobljena poročila o varnosti zdravila za to zdravilo predložiti v skladu z zahtevami, določenimi v seznamu referenčnih datumov Unije (seznamu EURD), opredeljenem v členu 107c(7) Direktive 2001/83/ES in objavljenem na evropskem spletnem portalu o zdravilih.
English: Paediatric population
Slovenian: • Pediatrična populacija
English: • if you have had an allergy or reaction to any medicine used to treat your disease.
Slovenian: • Če ste imeli alergijo ali alergijsko reakcijo na katero koli zdravilo, ki ste ga jemali.
English: For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:
Slovenian: Za katerokoli informacijo o tem zdravilu se obrnite na lokalnega predstavnika imetnika dovoljenja za promet z zdravilom.
English: You should take Clopidogrel Teva for as long as your doctor continues to prescribe it.
Slovenian: Zdravilo Klopidogrel Teva morate jemati, vse dokler vam ga vaš zdravnik predpisuje.
English: Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription.
Slovenian: Obvestite svojega zdravnika ali farmacevta, če uporabljate, ste pred kratkim uporabljali ali pa boste morda začeli uporabljati katero koli zdravilo, tudi če ste ga dobili brez recepta.
English: • If you are allergic to clopidogrel or any of the other ingredients of this medicine (listed in section
Slovenian: • Če ste alergični na klopidogrel ali katero koli sestavino tega zdravila (navedeno v poglavju 6).
English: Patients should be told that it might take longer than usual to stop bleeding when they take clopidogrel (alone or in combination with ASA), and that they should report any unusual bleeding (site or duration) to their physician.
Slovenian: Bolniki morajo biti obveščeni, da je lahko čas, potreben za zaustavitev krvavitve, daljši kot običajno, ko jemljejo klopidogrel (sam ali v kombinaciji z ASA) in da morajo poročati svojemu zdravniku o kakršnikoli neobičajni krvavitvi (mesto ali trajanje).
English: Other alleles associated with absent or reduced metabolism are less frequent and include CYP2C19*4, *5, *6, *7, and *8.
Slovenian: Drugimi aleli, povezani z odsotno ali zmanjšano presnovo, so redkejši in vključujejo CYP2C19*4, *5, *6, *7 in *8.
English: Cytochrome P450 2C19 (CYP2C19)
Slovenian: Citokrom P450-2C19 (CYP2C19)
English: If a dose is missed:
Slovenian: Če bolnik izpusti odmerek:
English: Do not take a double dose to make up for a forgotten tablet
Slovenian: Ne jemljite dvojnega odmerka, da bi nadomestili posamezno izpuščeno tableto.
English: In view of the lack of data, clopidogrel cannot be recommended during the first 7 days after acute ischaemic stroke.
Slovenian: Zaradi pomanjkanja podatkov, uporabe klopidogrela ne moremo priporočiti prvih 7 dni po akutni ishemični kapi.
English: If you stop taking Clopidogrel Teva Do not stop the treatment unless your doctor tells you so.
Slovenian: Če ste prenehali jemati zdravilo Klopidogrel Teva Ne prekinite zdravljenja razen, če tako odloči zdravnik.
English: • Your doctor may order blood tests.
Slovenian: • Vaš zdravnik vas bo morda poslal na dodatne preiskave krvi.
English: Clopidogrel Teva 75 mg
Slovenian: Klopidogrel Teva 75 mg
English: Adverse reactions that occurred either during clinical studies or that were spontaneously reported are presented in the table below.
Slovenian: Neželeni učinki, zabeleženi v kliničnih študijah ali o katerih so poročali spontano, so našteti v spodnji tabeli.
English: Push the tablet out.
Slovenian: Potisnite tableto skozi izpostavljeno folijo.
English: • If you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain.
Slovenian: • Če imate zdravstveno stanje, ki trenutno povzroča krvavitev, kot je razjeda na želodcu ali krvavitev v možganih.
English: Clopidogrel has no or negligible influence on the ability to drive and use machines.
Slovenian: Klopidogrel nima ali ima zanemarljiv vpliv na sposobnost vožnje in upravljanja s stroji.
English: Clopidogrel prolongs bleeding time and should be used with caution in patients who have lesions with a propensity to bleed (particularly gastrointestinal and intraocular).
Slovenian: Klopidogrel podaljša čas krvavitve in se mora uporabljati previdno pri bolnikih z lezijami, ki so nagnjeni h krvavitvam (zlasti gastrointestinalnim in intraokularnim).
English: This leaflet was last revised in {MM/YYYY}.
Slovenian: Navodilo je bilo nazadnje revidirano dne {mesec LLLL}.
English: You should have been told that ‘oral anticoagulants' are more effective than acetylsalicylic acid or the combined use of Clopidogrel Teva and acetylsalicylic acid for this condition.
Slovenian: Povedati so vam morali, da so "peroralni antikoagulanti" pri tej motnji učinkovitejši kot acetilsalicilna kislina ali kombinirana uporaba zdravila Klopidogrel Teva in acetilsalicilne kisline.
English: Patients with rare hereditary problems of galactose intolerance, total lactase deficiency or glucosegalactose malabsorption should not take this medicinal product.
Slovenian: Bolniki z redko dedno intoleranco za galaktozo, odsotnostjo encima laktaze ali malabsorpcijo glukoze/galaktoze ne smejo jemati tega zdravila.
English: One side of the tablet is debossed with the number “93”.
Slovenian: Ena stran tablete ima vtisnjeno številko »93«.
English: Bleeding may occur as bleeding in the stomach or bowels, bruising, haematoma (unusual bleeding or bruising under the skin), nose bleed or blood in the urine.
Slovenian: Krvavitve se lahko pojavijo kot krvavitve v želodec ali črevesje, modrice, hematomi (nenavadne krvavitve ali modrice pod kožo), krvavitev iz nosu ali kri v urinu.
English: Each film-coated tablet contains 59.05 mg of lactose (as monohydrate).
Slovenian: Ena filmsko obložena tableta vsebuje 59,05 mg laktoze (v obliki monohidrata).
English: Platelet aggregation and bleeding time gradually returned to baseline values, generally within 5 days after treatment was discontinued.
Slovenian: Agregacija trombocitov in čas krvavitve sta se postopoma vrnila na izhodiščno vrednost, v splošnem v 5 dneh po ukinitvi zdravljenja.
English: Other medicines and Clopidogrel Teva
Slovenian: Druga zdravila in zdravilo Klopidogrel Teva
English: • Signs of liver problems such as yellowing of the skin and /or the eyes (jaundice), whether or not associated with bleeding which appears under the skin as red pinpoint dots and/or confusion (see section 2 ‘Warnings and precautions').
Slovenian: • Znaki jeternih težav, kot je porumenelost kože in/ali oči (zlatenica), ki so lahko, ali pa ne, povezani s krvavitvijo, ki se pojavi pod kožo kot drobne rdeče pike, in/ali zmedenostjo (glejte poglavje 2 »Opozorila in previdnostni ukrepi«).
English: Then, the recommended dose is one 75-mg tablet of Clopidogrel Teva per day as described above.
Slovenian: Nato je priporočeni odmerek ena 75-mg tableta zdravila Klopidogrel Teva na dan, kot je opisano zgoraj.
English: • if you have kidney or liver disease.
Slovenian: • Če imate jetrne ali ledvične bolezni.
English: Separate one individual blister cell from the rest of the strip by gently tearing along the perforations around it.
Slovenian: Ločite posamezno pretisno celico od preostalega dela traka, tako da nežno pretrgate perforacijsko linijo okoli celice.
English: If you forget to take Clopidogrel Teva
Slovenian: Če ste pozabili vzeti zdravilo Klopidogrel Teva
English: • if you have had a clot in an artery of your brain (ischaemic stroke) which occurred within the last seven days
Slovenian: • Če se je v zadnjih sedmih dneh pri vas pojavil strdek v arteriji v možganih (ishemična kap).
English: What Clopidogrel Teva is and what it is used for
Slovenian: Kaj je zdravilo Klopidogrel Teva in za kaj ga uporabljamo
English: Bottles contain 30 or 100 film-coated tablets.
Slovenian: Plastenke vsebujejo 30 ali 100 filmsko obloženih tablet.
English: After single and repeated oral doses of 75 mg per day, clopidogrel is rapidly absorbed.
Slovenian: Po enkratnem ali večkratnih peroralnih odmerkih 75 mg na dan se klopidogrel hitro absorbira.
English: What you need to know before you take Clopidogrel Teva Do not take Clopidogrel Teva
Slovenian: Kaj morate vedeti, preden boste vzeli zdravilo Klopidogrel Teva Ne jemljite zdravila Klopidogrel Teva:
English: The most common side effect reported with Clopidogrel Teva is bleeding.
Slovenian: Najpogostejši neželeni učinek, o katerem so poročali z zdravilom Klopidogrel Teva je krvavitev.
English: • You should tell your doctor if a surgery (including dental) is planned.
Slovenian: • Zdravnika obvestite o načrtovani operaciji (tudi o zobozdravstveni).
English: The safety and efficacy of clopidogrel have been evaluated in 5 double-blind studies involving over 88,000 patients: the CAPRIE study, a comparison of clopidogrel to ASA, and the CURE, CLARITY, COMMIT and ACTIVE-A studies comparing clopidogrel to placebo, both medicinal products given in combination with ASA and other standard therapy.
Slovenian: Varnost in učinkovitost klopidogrela so vrednotili v 5 dvojno slepih študijah, v katere je bilo vključenih več kot 88.000 bolnikov: študija CAPRIE je obsegala primerjavo klopidogrela in ASA, v študijah CURE, CLARITY, COMMIT in ACTIVE-A pa so primerjali klopidogrel s placebom; obe zdravili pa so bolniki dobivali v kombinaciji z ASA in drugo standardno terapijo.
English: - a recent surgery (including dental).
Slovenian: o nedaven kirurški poseg (vključno na zobeh).
English: Clopidogrel Teva is unlikely to affect your ability to drive or to use machines.
Slovenian: Ni verjetno, da bi zdravilo Klopidogrel Teva vplivalo na vašo sposobnost za vožnjo ali upravljanje strojev.
English: Therapeutic experience with clopidogrel is limited in patients with renal impairment.
Slovenian: Ledvična okvara Terapevtske izkušnje s klopidogrelom so omejene pri bolnikih z ledvično okvaro.
English: Pharmacotherapeutic group: Antithrombotic agents, platelet aggregation inhibitors excl. heparin, ATC Code: B01AC04.
Slovenian: Farmakoterapevtska skupina: zaviralci agregacije trombocitov brez heparina, oznaka ATC: B01AC04.
English: If you have experienced severe chest pain (unstable angina or heart attack), you may be prescribed Clopidogrel Teva in combination with acetylsalicylic acid, a substance present in many medicines used to relieve pain and lower fever.
Slovenian: Če ste doživeli hudo bolečino v prsih (nestabilna angina pektoris ali srčni napad), so vam morda predpisali zdravilo Klopidogrel Teva v kombinaciji z acetilsalicilno kislino, učinkovino, ki je prisotna v številnih zdravilih, ki se uporabljajo za lajšanje bolečine in zniževanje zvišane telesne temperature.
English: Elimination Following an oral dose of 14C-labelled clopidogrel in man, approximately 50% was excreted in the urine and approximately 46% in the faeces in the 120-hour interval after dosing.
Slovenian: Po peroralnem odmerku s 14C-označenega klopidogrela pri človeku, se ga je približno 50 % izločilo z urinom in približno 46 % z blatom v 120 urnem intervalu po odmerjanju.
English: - a blood disorder that makes you prone to internal bleeding (bleeding inside any tissues, organs or joints of your body).
Slovenian: o krvna motnja, zaradi katere ste bolj nagnjeni k notranji krvavitvi (krvavitev v tkivih, organih ali sklepih vašega telesa).
English: (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100); rare (≥1/10,000 to <1/1,000); very rare
Slovenian: Njihova pogostnost je navedena upoštevaje naslednji dogovor: pogosti (≥1/100 do <1/10), občasni (≥1/1.000 do <1/100), redki (≥1/10.000 do <1/1.000), zelo redki (<1/10.000), neznani (ni mogoče oceniti iz razpoložljivih podatkov).
English: 75 mg-325 mg daily).
Slovenian: (75-325 mg enkrat na dan).
English: Due to the risk of bleeding and haematological adverse reactions, blood cell count determination and/or other appropriate testing should be promptly considered whenever clinical symptoms suggestive of bleeding arise during the course of treatment (see section 4.8).
Slovenian: Krvavitve in hematološke motnje Zaradi tveganja krvavitve in hematoloških neželenih učinkov moramo takoj pretehtati potrebo po določanju števila krvnih celic in/ali drugih ustreznih preiskav, kadarkoli se v času zdravljenja pojavijo klinični simptomi, ki nakazujejo krvavitev (glejte poglavje 4.8).
English: New cardiovascular events (primary endpoint) were prevented, with relative risk reductions of 22% (CI: 8.6, 33.4), 32% (CI: 12.8, 46.4), 4% (CI: -26.9, 26.7), 6% (CI: -33.5, 34.3) and 14% (CI: -31.6, 44.2), during the 0-1, 1-3, 3-6, 6-9 and 9-12 month study intervals, respectively.
Slovenian: Nove srčnožilne dogodke (primarni opazovani dogodek) so preprečili z zmanjšanjem relativnega tveganja: 22 % (IZ: 8,6, 33,4), 32 % (IZ: 12,8, 46,4), 4 % (IZ: -26,9, 26,7), 6 % (IZ: -33,5, 34,3) in 14 % (IZ: -31,6, 44,2) tekom 0-1, 1-3, 3-6, 6-9 oziroma 9-12 mesečnimi intervali študije.
English: • The film-coated tablets are light pink to pink, film coated, capsule shaped tablets.
Slovenian: • Filmsko obložene tablete so nežno rožnate do rožnate, v obliki kapsule.
English: Overall, clopidogrel 75 mg/day was comparable to ASA 325 mg/day in CAPRIE regardless of age, gender and race.
Slovenian: 75 mg/dan v študiji CAPRIE, primerljiv z ASA v odmerku 325 mg/dan, ne glede na starost, spol ali raso.
English: In poor metabolisers, active metabolite exposure was decreased by 63-71% compared to extensive metabolisers.
Slovenian: Pri slabih metabolizatorjih je bila izpostavljenost aktivnemu presnovku za 63 do71 % manjša kot pri dobrih metabolizatorjih.
English: In addition, a subgroup analysis by age suggested that the benefit of clopidogrel in patients over 75 years was less than that observed in patients ≤75 years.
Slovenian: Razen tega analiza podskupin glede na starost nakazuje, da so koristi klopidogrela pri bolnikih, starejših od 75 let,
English: Lactose monohydrate Hypromellose (E464) Titanium dioxide (E171) Macrogol 4000
Slovenian: Filmska obloga: laktoza monohidrat hipromeloza (E464) titanov dioksid (E171) makrogol 4000
English: • Fever, signs of infection or extreme tiredness.
Slovenian: • Zvišana telesna temperatura, znaki okužbe ali huda utrujenost.
English: For minor cuts and injuries, e.g., cutting yourself shaving, this is usually of no concern.
Slovenian: Pri manjših vrezninah ali poškodbah, npr. če se urežete ali britje, to navadno ni zaskrbljujoče.
English: − For more than 12 hours: patients should take the next dose at the regular scheduled time and should not double the dose.
Slovenian: − če je zamuda več kot 12 ur: bolnik naj naslednji odmerek vzame ob pravem času; odmerka ne sme podvojiti.
English: If you take more Clopidogrel Teva than you should
Slovenian: Če ste vzeli večji odmerek zdravila Klopidogrel Teva, kot bi smeli
English: In contrast, post-hoc analyses demonstrated statistically significant increases in the bleeding risk with the more potent P2Y12 inhibitors, occurring predominantly during the maintenance phase, after the first month post-ACS.
Slovenian: Nasprotno pa so post hoc analize pokazale, da je z močnejšimi zaviralci P2Y12 statistično značilno večje tveganje za krvavitve; krvavitve se pojavijo pretežno med fazo vzdrževalnega zdravljenja, po prvem mesecu po
English: Serum sickness, anaphylactoid reactions, cross-reactive drug hypersensitivity among thienopyridines (such as ticlopidine, prasugrel) (see section 4.4)*, insulin autoimmune syndrome, which can lead to severe hypoglycemia, particularly in patients with HLA DRA4 subtype (more frequent in the Japanese population)*
Slovenian: Bolezni imunskega sistema serumska bolezen, anafilaktoidne reakcije, navzkrižna preobčutljivost med tienopiridini (kot sta tiklopidin in prasugrel) (glejte poglavje 4.4)*, avtoimuni inzulinski sindrom, ki lahko vodi v resno hipoglikemijo, še posebej pri bolnikih s HLA DRA4 podtipom (pogostejši v japonski populaciji)*
English: Clopidogrel Teva is taken by adults to prevent blood clots (thrombi) forming in hardened blood vessels (arteries), a process known as atherothrombosis, which can lead to atherothrombotic events (such as stroke, heart attack, or death).
Slovenian: Zdravilo Klopidogrel Teva jemljejo odrasli za preprečevanje nastanka krvnih strdkov (trombov) v otrdelih krvnih žilah (arterijah), proces je znan kot aterotromboza in lahko vodi do aterotrombotičnih dogodkov (kot so kap, srčni napad ali smrt).
English: • Swelling in the mouth or skin disorders such as rashes and itching, blisters of the skin.
Slovenian: • Otekanje ust ali bolezni kože, kot so izpuščaji, srbečica in mehurji na koži.
English: The use of clopidogrel in CURE was associated with a decrease in the need of thrombolytic therapy (RRR=43.3%; CI: 24.3%, 57.5%) and GPIIb/IIIa inhibitors (RRR=18.2%; CI: 6.5%, 28.3%).
Slovenian: Uporaba klopidogrela v CURE je bila povezana z zmanjšano potrebo po zdravljenju s trombolitiki (zmanjšanje RT= 43,3 %; IZ: 24,3 %, 57,5 %) in inhibitorji glikoproteinov IIb/IIIa (zmanjšanje RT=18,2 %; IZ: 6,5 %, 28,3 %).
English: Consequently, NSAIDs including Cox-2 inhibitors and clopidogrel should be co-administered with caution (see section 4.4).
Slovenian: Zaradi tega moramo NSAIDs, vključno s COX-2 inhibitorji, in klopidogrel sočasno uporabljati previdno (glejte poglavje 4.4).